Cargando…
An Ultra-Sensitive Immunoassay for Quantifying Biomarkers in Breast Tumor Tissue
Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) have been validated at the highest level of evidence as clinical biomarkers of prognosis in breast cancer. The American Society of Clinical Oncology recommends using uPA and PAI-1 levels in breast tumors fo...
Autores principales: | Fowler, Carol B., Man, Yan-Gao, Mason, Jeffrey T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909766/ https://www.ncbi.nlm.nih.gov/pubmed/24494029 http://dx.doi.org/10.7150/jca.8084 |
Ejemplares similares
-
Breast cancer heterogeneity: mechanisms, proofs, and implications
por: Hsiao, Yi-Hsuan, et al.
Publicado: (2010) -
An Ultra-Sensitive Monoclonal Antibody-Based Competitive Enzyme Immunoassay for Sterigmatocystin in Cereal and Oil Products
por: Li, Min, et al.
Publicado: (2014) -
Eight-Channel AC Magnetosusceptometer of Magnetic Nanoparticles for High-Throughput and Ultra-High-Sensitivity Immunoassay
por: Chieh, Jen-Jie, et al.
Publicado: (2018) -
Ultra-sensitive isotope probing to quantify activity and substrate assimilation in microbiomes
por: Kleiner, Manuel, et al.
Publicado: (2023) -
Ultra-sensitive detection of protein biomarkers for diagnosis of Alzheimer’s disease
por: Chan, Hei-Nga, et al.
Publicado: (2017)